Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Ca...

FDA Drug Recall #D-1064-2020 — Class II — March 5, 2020

Recall Summary

Recall Number D-1064-2020
Classification Class II — Moderate risk
Date Initiated March 5, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fresenius Medical Care Holdings, Inc.
Location Waltham, MA
Product Type Drugs
Quantity 32,592 bags

Product Description

Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451

Reason for Recall

CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.

Distribution Pattern

Product was distributed throughout the United States.

Lot / Code Information

Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020

Other Recalls from Fresenius Medical Care Holdings, Inc.

Recall # Classification Product Date
D-0490-2025 Class II 0.9% Sodium Chloride Injection, USP, Flexible P... May 27, 2025
D-0608-2024 Class II DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW M... Jun 18, 2024
D-0218-2024 Class II DELFLEX Peritoneal Dialysis Solution in Biofine... Dec 28, 2023
D-0777-2023 Class II Sodium Chloride 0.9% Injection, USP, 1000 mL ba... May 23, 2023
D-0075-2023 Class II 0.9% Sodium Chloride Injection, USP, Each 100 m... Nov 22, 2022

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.